# Noam Solomon

> Noam Solomon is the Israeli co-founder and CEO of Immunai. He entered Tel Aviv University at 14, earned doctorates in number theory at Ben-Gurion University and computer science at Tel Aviv University, and held postdoctoral research positions at Harvard and MIT. His public interviews describe a move from theoretical research toward collaborative company building, with an emphasis on asking questions, assembling multidisciplinary teams and continuing to learn.

- **Role:** Co-founder and CEO at Immunai
- **Organizations:** Immunai, Massachusetts Institute of Technology, Harvard University, Tel Aviv University, Ben-Gurion University of the Negev
- **Nationality:** Israeli
- **Education:** Bachelor’s degree in computer science; Solomon also describes undergraduate mathematics studies, Tel Aviv University, MSc in mathematics, Ben-Gurion University of the Negev, PhD in number theory, Ben-Gurion University of the Negev, PhD in computer science, Tel Aviv University
- **Known for:** Earned two PhDs, in number theory and computer science., Selected as a 2017 Rothschild Fellow., Received a 2006 Friedman Prize for his MSc thesis.

## Career timeline

- **Age 14** — Entered university at Tel Aviv University.
- **2006** — Received a Friedman Prize for his MSc thesis at Ben-Gurion University, supervised by Amnon Besser.
- **2017-2018** — CMSA postdoctoral fellow at Harvard University.
- **2018-2019** — Rothschild Fellow and postdoctoral associate in MIT’s mathematics department; Larry Guth’s CV records October 2018 through March 2019.
- **2018** — Co-founded Immunai; the company gives December 2018 as its founding date.
- **2019** — Co-authored Closure Results for Polynomial Factorization, published November 1 in Theory of Computing.
- **2023** — Published an opinion essay proposing a psychological Turing Test.
- **2024** — Discussed his academic and entrepreneurial career in a four-part conversation on The Biotech Startups Podcast.

## Achievements

- Earned two PhDs, in number theory and computer science.
- Selected as a 2017 Rothschild Fellow.
- Received a 2006 Friedman Prize for his MSc thesis.
- Co-authored a 2019 paper establishing that the complexity class VNP is closed under taking factors.
- Co-founded Immunai in December 2018 and serves as CEO.

## Latest updates

- **2026-01** — Featured in a Forbes Israel interview published January 11, discussing company building, research infrastructure and the long time horizon of scientific ventures.
- **2024-11** — Appeared on Impact AI with Heather Couture; the episode was published November 4.
- **2024-07** — BINA documented his conversation with BINA and AION Labs on July 10, emphasizing problem focus, teams and lifelong learning.

## Links

- Website: https://www.immunai.com/
- LinkedIn: https://www.linkedin.com/in/noam-solomon-142393129/
- Twitter/X: https://x.com/noamsolomon1

---

Profile page: https://yespress.io/noam-solomon
Published by YesPress — https://yespress.io
Last updated: 2026-10-26